112 related articles for article (PubMed ID: 38143008)
1. Neuroprotective role of FOXA1 in Parkinson's disease: Involvements of NF1 transcription activation and MAPK signaling pathway inhibition.
Fan Y; Zhao M; Hao F; Sun R; Chen J; Liu J
Brain Res Bull; 2024 Jan; 206():110860. PubMed ID: 38143008
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
3. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
Park JS; Choe K; Lee HJ; Park TJ; Kim MO
J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.
Shadfar S; Kim YG; Katila N; Neupane S; Ojha U; Bhurtel S; Srivastav S; Jeong GS; Park PH; Hong JT; Choi DY
Mol Neurobiol; 2018 Jan; 55(1):554-566. PubMed ID: 27975170
[TBL] [Abstract][Full Text] [Related]
6. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the TLR/NF-
Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J
Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
9. Resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in Parkinson disease models.
Lim HS; Park G
Neurosci Lett; 2022 Jun; 781():136667. PubMed ID: 35490904
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
11. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
Choi YJ; Kim DW; Shin MJ; Yeo HJ; Yeo EJ; Lee LR; Song Y; Kim DS; Han KH; Park J; Lee KW; Park JK; Eum WS; Choi SY
Molecules; 2021 Jun; 26(11):. PubMed ID: 34206041
[TBL] [Abstract][Full Text] [Related]
12. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
13. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
Seo MH; Yeo S
Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
15. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo.
Doo AR; Kim SN; Park JY; Cho KH; Hong J; Eun-Kyung K; Moon SK; Jung WS; Lee H; Jung JH; Park HJ
J Ethnopharmacol; 2010 Sep; 131(2):433-42. PubMed ID: 20633628
[TBL] [Abstract][Full Text] [Related]
17. PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model.
Ahn EH; Kim DW; Shin MJ; Kim YN; Kim HR; Woo SJ; Kim SM; Kim DS; Kim J; Park J; Eum WS; Hwang HS; Choi SY
Free Radic Biol Med; 2013 Feb; 55():36-45. PubMed ID: 23178948
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic neuroprotective effects of inosine in MPTP-induced parkinsonian mice via brain-derived neurotrophic factor upregulation.
Khanal S; Bok E; Kim J; Park GH; Choi DY
Neuropharmacology; 2023 Nov; 238():109652. PubMed ID: 37422180
[TBL] [Abstract][Full Text] [Related]
19. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
Yang J; Jia M; Zhang X; Wang P
Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
[TBL] [Abstract][Full Text] [Related]
20. In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin.
Santoro M; Maetzler W; Stathakos P; Martin HL; Hobert MA; Rattay TW; Gasser T; Forrester JV; Berg D; Tracey KJ; Riedel G; Teismann P
Neurobiol Dis; 2016 Jul; 91():59-68. PubMed ID: 26921471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]